Time-perioda | Term | Number of unique genesb | Total number of genesc | P-value | FDR |
---|---|---|---|---|---|
HS time-period 1 | ssc04137: Mitophagy—animal | 17 | 64 | 0.047 | 0.195 |
(TV: 39.741 ± 0.724DP: 22.080 ± 2.060) |  |  |  |  |  |
HS time-period 2 | ssc04744: Phototransduction | 7 | 68 | 0.006 | 0.012 |
(TV: 39.134 ± 0.620DP: 22.844 ± 2.084) | ssc04727: GABAergic synapse |  |  | 0.020 | 0.012 |
ssc05032: Morphine addiction | Â | Â | 0.021 | 0.012 | |
ssc04713: Circadian entrainment | Â | Â | 0.022 | 0.012 | |
ssc04724: Glutamatergic synapse | Â | Â | 0.025 | 0.012 | |
ssc04725: Cholinergic synapse | Â | Â | 0.025 | 0.012 | |
ssc04726: Serotonergic synapse | Â | Â | 0.026 | 0.012 | |
ssc04380: Osteoclast differentiation | Â | Â | 0.028 | 0.012 | |
ssc04728: Dopaminergic synapse | Â | Â | 0.029 | 0.012 | |
ssc04926: Relaxin signaling pathway | Â | Â | 0.029 | 0.012 | |
ssc04371: Apelin signaling pathway | Â | Â | 0.031 | 0.012 | |
ssc04723: Retrograde endocannabinoid signaling | Â | Â | 0.033 | 0.012 | |
ssc05034: Alcoholism | Â | Â | 0.038 | 0.012 | |
ssc04062: Chemokine signaling pathway | Â | Â | 0.041 | 0.012 | |
ssc05167: Kaposi sarcoma-associated herpesvirus infection | Â | Â | 0.044 | 0.012 | |
ssc05170: Human immunodeficiency virus 1 infection | Â | Â | 0.049 | 0.012 | |
HS time-period 3 | ssc04916: Melanogenesis | 18 | 70 |  < 0.001 | 0.014 |
(TV: 39.771 ± 0.729 DP: 23.843 ± 2.478) | ssc04921: Oxytocin signaling pathway |  |  | 0.001 | 0.016 |
ssc04934: Cushing syndrome | Â | Â | 0.001 | 0.016 | |
ssc04213: Longevity regulating pathway—multiple species |  |  | 0.002 | 0.035 | |
ssc05217: Basal cell carcinoma | Â | Â | 0.003 | 0.035 | |
ssc04211: Longevity regulating pathway | Â | Â | 0.005 | 0.049 | |
ssc05410: Hypertrophic cardiomyopathy | Â | Â | 0.005 | 0.049 | |
ssc05414: Dilated cardiomyopathy | Â | Â | 0.006 | 0.049 | |
ssc04371: Apelin signaling pathway | Â | Â | 0.012 | 0.067 | |
ssc04550: Signaling pathways regulating pluripotency of stem cells | Â | Â | 0.013 | 0.067 | |
ssc04261: Adrenergic signaling in cardiomyocytes | Â | Â | 0.013 | 0.067 | |
ssc05224: Breast cancer | Â | Â | 0.013 | 0.067 | |
ssc05226: Gastric cancer | Â | Â | 0.014 | 0.067 | |
ssc04150: mTOR signaling pathway | Â | Â | 0.015 | 0.067 | |
ssc04390: Hippo signaling pathway | Â | Â | 0.015 | 0.067 | |
ssc05225: Hepatocellular carcinoma | Â | Â | 0.016 | 0.068 | |
ssc04310: Wnt signaling pathway | Â | Â | 0.017 | 0.068 | |
ssc05207: Chemical carcinogenesis—receptor activation |  |  | 0.025 | 0.091 | |
ssc05205: Proteoglycans in cancer | Â | Â | 0.026 | 0.091 | |
ssc04714: Thermogenesis | Â | Â | 0.032 | 0.108 | |
ssc04710: Circadian rhythm | Â | Â | 0.042 | 0.136 | |
HS time-period 4 | ssc00240: Pyrimidine metabolism | 11 | 51 | 0.018 | 0.006 |
(TV: 40.125 ± 0.687 DP: 23.226 ± 1.996) | ssc04924: Renin secretion |  |  | 0.023 | 0.006 |
ssc04742: Taste transduction | Â | Â | 0.024 | 0.006 | |
ssc01232: Nucleotide metabolism | Â | Â | 0.027 | 0.006 | |
ssc05032: Morphine addiction | Â | Â | 0.031 | 0.006 | |
ssc03040: Spliceosome | Â | Â | 0.042 | 0.006 | |
ssc00230: Purine metabolism | Â | Â | 0.043 | 0.006 |